FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894083008> ?p ?o ?g. }

• W2894083008 abstract "Cancer stem cells (CSC) are characterized by deregulated self-renewal, tumorigenicity, metastatic potential, aberrant stemness signaling pathways, resistance to conventional therapy, and the ability to give rise to a progeny of proliferating cells that constitute the bulk of tumors. Targeting CSC will provide novel treatments for cancer. Different investigations have focused on developing complementary approaches that involve natural compounds that decrease chemo-resistance and reduce the side effects of conventional therapies. Since, it has been reported that molecular iodine (I2) exhibits antineoplastic effects and decreases tumor progression in some cancer models, we evaluated the potential effect of I2 on cell cultures enriched in cervical cancer stem-like cells. HeLa and SiHa cervical cancer cells were treated with 200uM I2 for 24 h. After time, cells were cultured in CSC-conditioned medium (cervospheres) and viability assays were performed. Following, tumorigenic capabilities in cervospheres treated with I2 were evaluated in NOD/SCID mice. HeLa monolayer cells untreated and their respective cervosphere cells treated or untreated with 200 μM of I2 for 24 h were xenotransplanted subcutaneously at different amounts and mice were monitored for at least 2 months. In the present study, monolayer and CSC-enriched cultures (cervospheres) from cervical cancer-derived cell lines, HeLa and SiHa, showed that 200uM I2 supplementation inhibits proliferation of both and decreased their tumorigenic capacity, in vivo. This antineoplastic effect of I2 was accompanied by diminished expression of stemness markers including CD49f, CK17, OCT-4, NANOG, SOX2, and KLF4, as well as increased expression and activation of PPARγ receptors. All this data led us to suggest a clinical potential use of I2 for targeting CSC and improve current treatments against cervical cancer." @default.
• W2894083008 created "2018-10-05" @default.
• W2894083008 creator A5026070077 @default.
• W2894083008 creator A5032021043 @default.
• W2894083008 creator A5036763424 @default.
• W2894083008 creator A5049939191 @default.
• W2894083008 creator A5058805335 @default.
• W2894083008 creator A5059545212 @default.
• W2894083008 date "2018-09-26" @default.
• W2894083008 modified "2023-10-18" @default.
• W2894083008 title "Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer" @default.
• W2894083008 cites W1491450961 @default.
• W2894083008 cites W1513052380 @default.
• W2894083008 cites W1548499384 @default.
• W2894083008 cites W171595586 @default.
• W2894083008 cites W1757407923 @default.
• W2894083008 cites W1828182586 @default.
• W2894083008 cites W1866062034 @default.
• W2894083008 cites W1911233385 @default.
• W2894083008 cites W1964635816 @default.
• W2894083008 cites W1966735534 @default.
• W2894083008 cites W1979981202 @default.
• W2894083008 cites W1982396632 @default.
• W2894083008 cites W1983609116 @default.
• W2894083008 cites W1984512827 @default.
• W2894083008 cites W1986869728 @default.
• W2894083008 cites W1987084841 @default.
• W2894083008 cites W1994229067 @default.
• W2894083008 cites W1995646224 @default.
• W2894083008 cites W1996762696 @default.
• W2894083008 cites W1997006958 @default.
• W2894083008 cites W1997260939 @default.
• W2894083008 cites W1997666947 @default.
• W2894083008 cites W2010512766 @default.
• W2894083008 cites W2013653563 @default.
• W2894083008 cites W2015832228 @default.
• W2894083008 cites W2021401668 @default.
• W2894083008 cites W2023427658 @default.
• W2894083008 cites W2025021524 @default.
• W2894083008 cites W2029372290 @default.
• W2894083008 cites W2030343270 @default.
• W2894083008 cites W2042483088 @default.
• W2894083008 cites W2051055358 @default.
• W2894083008 cites W2059711021 @default.
• W2894083008 cites W2073759231 @default.
• W2894083008 cites W2075913659 @default.
• W2894083008 cites W2088861927 @default.
• W2894083008 cites W2092534258 @default.
• W2894083008 cites W2094387719 @default.
• W2894083008 cites W2098765233 @default.
• W2894083008 cites W2102085111 @default.
• W2894083008 cites W2103938764 @default.
• W2894083008 cites W2105035717 @default.
• W2894083008 cites W2112350806 @default.
• W2894083008 cites W2123473989 @default.
• W2894083008 cites W2130859532 @default.
• W2894083008 cites W2138143726 @default.
• W2894083008 cites W2161983416 @default.
• W2894083008 cites W2167650288 @default.
• W2894083008 cites W2169832079 @default.
• W2894083008 cites W2278204420 @default.
• W2894083008 cites W2299969113 @default.
• W2894083008 cites W2305146800 @default.
• W2894083008 cites W2312971723 @default.
• W2894083008 cites W2335809524 @default.
• W2894083008 cites W2570959155 @default.
• W2894083008 cites W2612644346 @default.
• W2894083008 cites W2750882609 @default.
• W2894083008 cites W278950519 @default.
• W2894083008 doi "https://doi.org/10.1186/s12885-018-4824-5" @default.
• W2894083008 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6158890" @default.
• W2894083008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30257666" @default.
• W2894083008 hasPublicationYear "2018" @default.
• W2894083008 type Work @default.
• W2894083008 sameAs 2894083008 @default.
• W2894083008 citedByCount "13" @default.
• W2894083008 countsByYear W28940830082018 @default.
• W2894083008 countsByYear W28940830082019 @default.
• W2894083008 countsByYear W28940830082020 @default.
• W2894083008 countsByYear W28940830082021 @default.
• W2894083008 countsByYear W28940830082022 @default.
• W2894083008 countsByYear W28940830082023 @default.
• W2894083008 crossrefType "journal-article" @default.
• W2894083008 hasAuthorship W2894083008A5026070077 @default.
• W2894083008 hasAuthorship W2894083008A5032021043 @default.
• W2894083008 hasAuthorship W2894083008A5036763424 @default.
• W2894083008 hasAuthorship W2894083008A5049939191 @default.
• W2894083008 hasAuthorship W2894083008A5058805335 @default.
• W2894083008 hasAuthorship W2894083008A5059545212 @default.
• W2894083008 hasBestOaLocation W28940830081 @default.
• W2894083008 hasConcept C104317684 @default.
• W2894083008 hasConcept C107459253 @default.
• W2894083008 hasConcept C121608353 @default.
• W2894083008 hasConcept C126322002 @default.
• W2894083008 hasConcept C136302470 @default.
• W2894083008 hasConcept C145103041 @default.
• W2894083008 hasConcept C185592680 @default.
• W2894083008 hasConcept C207701140 @default.
• W2894083008 hasConcept C2777366897 @default.
• W2894083008 hasConcept C2777933648 @default.

• next